Defining Health Across the Cancer Continuum

Dulaney, Caleb; Wallace, Audrey S.; Everett, Ashlyn S.; Dover, Laura; McDonald, Andrew; Kropp, L.

doi:10.7759/cureus.1029

Cited by 18 publications

(13 citation statements)

References 25 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Advances in cancer screening and early detection, as well as improvements in treatment and supportive care have contributed to decreasing cancer‐related mortality and increasing cancer survivorship 2 . With the increasing number of cancer survivors, there is a critical need to address cancer‐related symptoms, such as chronic pain, fatigue, anxiety, and depression 3 …”

Section: Introductionmentioning

confidence: 99%

Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample

Elizabeth

Ksinan

Kim

et al. 2021

Cancer

View full text Add to dashboard Cite

Background Research on cannabis use among those with a history of cancer is limited. Methods Prevalence of past‐year cannabis use among individuals with and without a cancer history and predictors of use within these 2 groups were determined using data from the Population Assessment of Tobacco and Health study, a nationally representative, longitudinal survey conducted in the United States (waves 1‐4; 2013‐2018). Discrete time survival analyses were used to estimate baseline (wave 1) predictors (physical health status, mental health status, pain, and demographic variables) on past‐year engagement with cannabis within individuals who reported a cancer diagnosis at wave 1 (n = 1022) and individuals who reported never having cancer at any wave (n = 19,702). Results At the most recent survey, 8% of cancer survivors reported past‐year cannabis use, compared with 15% of those without a cancer history. Across 4 time points, an estimated 3.8% of cancer survivors engaged with cannabis, as compared to 6.5% of those without a cancer history. Across both groups, older age and having health insurance were associated with lower likelihood of engaging in cannabis use, whereas greater levels of pain were associated with higher likelihood of engaging in cannabis use. Among those without a cancer history, being female, White, and having better mental health status were associated with lower likelihood of engaging in cannabis use. Conclusions Although cannabis use prevalence is lower among cancer survivors, the reasons for use are not markedly different from those without a cancer history. Continued monitoring of use, reasons for use, and harms or benefits is warranted. Lay Summary Results from this study, which uses data from the Population Assessment of Tobacco and Health Study, indicate that cannabis use is generally increasing across cancer survivors and those without a history of cancer. Cancer survivors are using cannabis at slightly lower rates than those without a history of cancer. Factors related to pain seem to be more prevalent in cancer populations relative to the general population, and could be contributing to cannabis use within cancer survivor populations.

show abstract

Section: Introductionmentioning

confidence: 99%

Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample

Elizabeth

Ksinan

Kim

et al. 2021

Cancer

View full text Add to dashboard Cite

show abstract

“…For patients with advanced cancer, the discussion about the prognosis and the integration with palliative care may positively impact the quality of life, since the proposed treatments do not always contribute to relieve symptoms and prevent the progression of the disease, as shown in literature (16) . In addition, it must be considered that the progression of the disease contributes to worsen the quality of life, as evidenced in randomized study carried out with 733 patients with advanced or metastatic lung cancer submitted to different treatments (17) .…”

Section: Discussionmentioning

confidence: 99%

Perception of cancer patients in palliative care about quality of life

2018

View full text Add to dashboard Cite

show abstract

“…Health related quality of life (QOL) is not the absence of disease or suffering but is largely a response to a series of life events that influence quality and quantity of life (1). QOL can also be defined as a subjective evaluation of life as good or satisfactory overall.…”

Section: What Is Quality Of Life?mentioning

confidence: 99%

“…Currently, most of the QOL questionnaires in palliative care have fixed number of items. Consolidated effort from the research community is needed to further (1) validate existing QOL questionnaires at various stages along the disease trajectory, (2) define their MCIDs to allow proper power calculation for clinical trials and interpretation of findings, and (3) assess their clinical utility to facilitate cost- effectiveness analyses for various palliative care interventions. At the same time, active efforts are underway to develop newer QOL questionnaires that can be more personalized to the individual’s care goals based on computerized adaptive testing.…”

Section: Five-year Viewmentioning

confidence: 99%

Quality of life in palliative care

Davis

Hui²

2017

Expert Review of Quality of Life in Cancer Care

View full text Add to dashboard Cite

Introduction: A main goals of palliative care is to improve the health-related quality of life (QOL) of patients with advanced illnesses. The objective of this narrative review is to provide an updated synopsis on the use of QOL questionnaires in the palliative care setting. Areas covers: Focusing on the palliative cares setting, we will define QOL, discuss how QOL instruments can be used clinically and in research, review approaches to validate these questionnaires, and how they can be used in utility analyses. Expert opinion/commentary: Several QOL questionnaires, such as EORTC-QLQ-C30, McGill QOL questionnaire and EQ-5D have been validated in the palliative care setting. However, significant gaps impede their application, including lack of determination of their responsiveness to change and minimal clinically important differences, the need to conduct more psychometric validation on QOL questionnaires among patients at various stages of disease trajectory, and the paucity of studies examining utility and cost-effectiveness. Further research is needed to address these knowledge gaps so QOL questionnaires can be better used to inform clinical practice and research.

show abstract

Defining Health Across the Cancer Continuum

Cited by 18 publications

References 25 publications

Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample

Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample

Perception of cancer patients in palliative care about quality of life

Quality of life in palliative care

Contact Info

Product

Resources

About